Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ekir.2016.08.019 http://scihub22266oqcxt.onion/10.1016/j.ekir.2016.08.019 C5678839!5678839 !29142946     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29142946 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Kidney+Int+Rep 2017 ; 2 (1 ): 89-90 Nephropedia Template TP {{tp|p=29142946 |t=2017. CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy |pdf=|usr=}}{{29142946 }} gab.com Text CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy JO: Kidney Int Rep http://www.kidney.de/pget.php?&tw=1&pmid=29142946 #FOAvip ? Twit Text FOAVip CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy ????Kidney Int Rep http://www.kidney.de/pget.php?&tw=1&pmid=29142946 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29142946 #FOAvip English Wikipedia <ref>{{Cite pmid|29142946 }}</ref> CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy #MMPMID29142946 Ramachandran R ; Yadav AK ; Kumar V ; Gupta KL ; Kohli HS Kidney Int Rep 2017[Jan]; 2 (1 ): 89-90 PMID29142946 show ga ? ?CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Ref(epmc).pdf DeepDyve Pubget Overpricing